<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2025-262
Date of Submission: 2025-02-09

This report was submitted by a Patient from Johnson-Vazquez Medical Center concerning patient ANON-PX-3091. The subject is a 58-year-old other with a significant medical history including anxiety, migraines. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Atorvastatin (Statin) administered via the Intravenous route at a dosage of 38mg, initiated on 2025-01-19 for Hypercholesterolemia with the course ongoing.

On approximately 2025-01-31, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Vomiting, Headache. The Vomiting was classified as Severe in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovering'. The Headache was classified as Moderate in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovering'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Positive dechallenge'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Talk level husband trial. Choose student traditional call million. Major series long reflect.</data>
report_id: ADR-2025-262
report_date: '2025-02-09'
patient_details:
  patient_id: ANON-PX-3091
  gender: Other
  relevant_history:
  - anxiety
  - migraines
  age_at_reaction: 58
suspected_drugs:
- drug_name: Atorvastatin
  dosage: 38mg
  route_of_administration: Intravenous
  start_date: '2025-01-19'
  indication_for_use: Hypercholesterolemia
  drug_class: Statin
adverse_reactions:
- symptom_name: Vomiting
  onset_date: '2025-01-31'
  severity: Severe
  outcome: Recovering
  intervention_required: false
- symptom_name: Headache
  onset_date: '2025-01-31'
  severity: Moderate
  outcome: Recovering
  intervention_required: false
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Positive dechallenge
reporting_facility: Johnson-Vazquez Medical Center
reporter_type: Patient
notes: Talk level husband trial. Choose student traditional call million. Major series
  long reflect.
